GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soiken Holdings Inc (TSE:2385) » Definitions » EV-to-EBIT

Soiken Holdings (TSE:2385) EV-to-EBIT : 1.00 (As of Jun. 06, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Soiken Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Soiken Holdings's Enterprise Value is 円-621 Mil. Soiken Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was 円-619 Mil. Therefore, Soiken Holdings's EV-to-EBIT for today is 1.00.

The historical rank and industry rank for Soiken Holdings's EV-to-EBIT or its related term are showing as below:

TSE:2385' s EV-to-EBIT Range Over the Past 10 Years
Min: -476.08   Med: 10.47   Max: 719.35
Current: 1.01

During the past 13 years, the highest EV-to-EBIT of Soiken Holdings was 719.35. The lowest was -476.08. And the median was 10.47.

TSE:2385's EV-to-EBIT is ranked better than
67.45% of 424 companies
in the Biotechnology industry
Industry Median: 9.96 vs TSE:2385: 1.01

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Soiken Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was 円-683 Mil. Soiken Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was 円-619 Mil. Soiken Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 90.62%.


Soiken Holdings EV-to-EBIT Historical Data

The historical data trend for Soiken Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soiken Holdings EV-to-EBIT Chart

Soiken Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.20 9.09 8.58 2.29 2.90

Soiken Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 2.90 6.17 4.03 1.10

Competitive Comparison of Soiken Holdings's EV-to-EBIT

For the Biotechnology subindustry, Soiken Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Soiken Holdings's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soiken Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Soiken Holdings's EV-to-EBIT falls into.



Soiken Holdings EV-to-EBIT Calculation

Soiken Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-621.314/-619.218
=1.00

Soiken Holdings's current Enterprise Value is 円-621 Mil.
Soiken Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-619 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Soiken Holdings  (TSE:2385) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Soiken Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-619.218/-683.3086
=90.62 %

Soiken Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was 円-683 Mil.
Soiken Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-619 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Soiken Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Soiken Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Soiken Holdings (TSE:2385) Business Description

Traded in Other Exchanges
N/A
Address
1-4-2 Shinsenri-Higashimachi, 13th Floor, Senri Life Science Center, Toyonaka, Osaka, JPN, 560-0082
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.

Soiken Holdings (TSE:2385) Headlines

No Headlines